Zydus Lifesciences Ltd. (Formerly Known As Cadila Healthcare Ltd.) Has Received Final Approval From The Us Fda To Market Generic Colestipol Hydrochloride Tablets In The Strength Of 1Mg.Colestipol Hydrochloride Tablets Are Indicated As Adjunctive Therapy To Diet For The Reduction Of Elevated Serum Total And Ldl-C In Patients With Primary Hypercholesterolemia (Elevated Ldl-C) Who Do Not Respond Adequately To Diet. Colestipol Hydrochloride Is A Highly Complex Macro Molecule Drug Substance With Little Or No Systemic Absorption.Zydus
